Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Clinical trials

Disease Area Clinical trials

Biting Back Against Malaria

| William Aryitey

A small clinical trial has shown that a malaria vaccine works in humans

Tools & Techniques Clinical trials

Into the Patient (The Art of Translation)

Translation in action, as science and engineering turns to medicine

Outside the Lab Clinical trials

See-Through Science at GSK

| Murray Stewart

Opening up our clinical trial results takes investment, but it's the right thing to do

Outside the Lab Clinical trials

The March Towards Trial Transparency

| James Cockerill

Many clinical trial results are never reported, but AllTrials hopes to change that

Tools & Techniques Animal models

Lost in Translation?

| Pascal Sanchez, Steve Finkbeiner, Kate Possin

Scientists from opposite ends of the translational spectrum have teamed up to help solve a pressing problem in Alzheimer’s research. By creating a human equivalent to the water mazes used in rodent studies, they hope to allow easier comparison of data from animal and human studies.

Tools & Techniques Neuroscience

Shocking New Therapy

| William Aryitey

The road to recovery for victims of stroke can be arduous and involve relearning basic skills and activities.

Research Field Neuroscience

Shocking New Therapy

| William Aryitey

Stroke sufferers may benefit from mild electrical stimulation of the brain

Tools & Techniques Cancer

Video: Inside The Translational Scientist

| Charlotte Barker

Want a lightning-fast tour of the latest issue? Take a look at our new video sneak preview.

Tools & Techniques Cancer

Immune U-Turn

| Charlotte Barker

“Extraordinary” results from a T-cell therapy trial offer hope to leukemia patients – and to researchers toiling in unfashionable fields.

Research Field Cancer

No Biomarker, No Trial?

| James Ritchie, Sidath Katugampola, Paul Jones

The vast majority of experimental cancer drugs fail during the later stages of clinical development

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts